Aytu Biopharma Inc
AYTU2.390USD
+0.090+3.91%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
23.69MCap. mercado
PérdidaP/E TTM
Más Datos de Aytu Biopharma Inc Compañía
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Información de Aytu Biopharma Inc
Símbolo de cotizaciónAYTU
Nombre de la empresaAytu Biopharma Inc
Fecha de salida a bolsaOct 20, 2017
Director ejecutivoDisbrow (Joshua R)
Número de empleados82
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 20
Dirección7900 E. Union Avenue
CiudadDENVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80237
Teléfono17204376580
Sitio Webhttps://aytubio.com/
Símbolo de cotizaciónAYTU
Fecha de salida a bolsaOct 20, 2017
Director ejecutivoDisbrow (Joshua R)
Ejecutivos de Aytu Biopharma Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
Estadísticas de accionistas
Actualizado: vie., 6 de feb
Actualizado: vie., 6 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
Otro
70.66%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
Otro
70.66%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
15.55%
Hedge Fund
15.19%
Individual Investor
5.13%
Investment Advisor
3.26%
Bank and Trust
0.03%
Otro
60.84%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
65
3.65M
34.03%
-127.44K
2025Q3
63
3.62M
35.61%
+200.00K
2025Q2
63
3.42M
23.61%
+1.37M
2025Q1
58
1.88M
32.85%
-147.25K
2024Q4
61
1.88M
35.64%
-167.56K
2024Q3
65
2.05M
38.87%
-5.48K
2024Q2
68
2.06M
35.52%
+258.31K
2024Q1
72
1.80M
39.85%
-420.62K
2023Q4
75
1.77M
40.04%
+44.24K
2023Q3
81
1.73M
39.72%
+20.75K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
1.09M
10.67%
--
--
Sep 30, 2025
Stonepine Capital Management, LLC
891.86K
8.75%
+79.18K
+9.74%
Sep 30, 2025
AWM Investment Company, Inc.
619.57K
6.08%
-300.00
-0.05%
Sep 30, 2025
The Vanguard Group, Inc.
278.58K
2.73%
+250.69K
+898.94%
Sep 30, 2025
Diadema Partners LP
272.67K
2.68%
+272.67K
--
Sep 30, 2025
Disbrow (Joshua R.)
207.20K
2.03%
+53.95K
+35.20%
Oct 13, 2025
Lytton (Laurence W)
122.06K
1.2%
-384.54K
-75.91%
Sep 30, 2025
Two Sigma Investments, LP
108.54K
1.07%
+73.50K
+209.79%
Sep 30, 2025
Renaissance Technologies LLC
95.12K
0.93%
+5.21K
+5.79%
Sep 30, 2025
Geode Capital Management, L.L.C.
71.01K
0.7%
+17.14K
+31.81%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
